Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$407K Buy
8,368
+71
+0.9% +$3.21K 0.01% 133
2017
Q1
$368K Buy
+8,297
New +$359K 0.01% 137
2016
Q4
Sell
-8,335
Closed -$352K 235
2016
Q3
$352K Sell
8,335
-347
-4% -$14.9K 0.01% 128
2016
Q2
$341K Sell
8,682
-121
-1% -$4.82K 0.02% 132
2016
Q1
$368K Sell
8,803
-636
-7% -$25.2K 0.02% 117
2015
Q4
$424K Sell
9,439
-7,550
-44% -$333K 0.02% 103
2015
Q3
$683K Sell
16,989
-2,111
-11% -$99.5K 0.04% 101
2015
Q2
$937K Sell
19,100
-1,487
-7% -$71.4K 0.04% 91
2015
Q1
$953K Buy
20,587
+10
+0% +$459 0.05% 93
2014
Q4
$927K Buy
20,577
+2,122
+11% +$92.4K 0.05% 93
2014
Q3
$768K Sell
18,455
-215
-1% -$9.1K 0.05% 105
2014
Q2
$763K Buy
18,670
+75
+0.4% +$2.94K 0.05% 110
2014
Q1
$716K Buy
18,595
+430
+2% +$16.6K 0.05% 108
2013
Q4
$696K Sell
18,165
-14,792
-45% -$545K 0.05% 108
2013
Q3
$1.09M Buy
32,957
+5,601
+20% +$197K 0.09% 65
2013
Q2
$954K Buy
+27,356
New +$1M 0.08% 44

Other funds holding ABT

Ronald Blue & Co's ABT Position: Q2 2017 in Review

Ronald Blue & Co increased its Abbott (ABT) stake by 0.86% in Q2 2017, buying an estimated $3.21K and bringing the position to 8,368 shares worth $407K. The position accounts for 0.01% of the portfolio, ranked #133.

Ronald Blue & Co first reported a position in ABT in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.09M in Q3 2013. 1,577 funds tracked by Wall St. Rank hold ABT as of Q2 2017.

  • Ronald Blue & Co held 8,368 shares of Abbott worth $407K as of Q2 2017.
  • Ronald Blue & Co bought 71 Abbott shares in Q2 2017, an estimated $3.21K.
  • Abbott made up 0.01% of Ronald Blue & Co's portfolio in Q2 2017, its #133 holding.
  • Ronald Blue & Co first reported a position in Abbott in Q2 2013 and has held it in 16 quarters since.
  • Ronald Blue & Co's Abbott position peaked at $1.09M in Q3 2013.
  • 1,577 funds tracked by Wall St. Rank held Abbott as of Q2 2017.

Based on Ronald Blue & Co's 13F filing for Q2 2017, filed 28 Jul 2017.